SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-22-111196
Filing Date
2022-04-20
Accepted
2022-04-20 16:43:53
Documents
3
Period of Report
2022-06-01

Document Format Files

Seq Description Document Type Size
1 DEF 14A d291450ddef14a.htm DEF 14A 459969
2 GRAPHIC g291450g01a11.jpg GRAPHIC 226218
3 GRAPHIC g291450g02s22.jpg GRAPHIC 174786
  Complete submission text file 0001193125-22-111196.txt   1013467
Mailing Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080
Business Address 343 OYSTER POINT BLVD #200 SOUTH SAN FRANCISCO CA 94080 650-870-1000
Calithera Biosciences, Inc. (Filer) CIK: 0001496671 (see all company filings)

IRS No.: 272366329 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-36644 | Film No.: 22838645
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences